Pharmacotherapy of PTSD in the U.S. Department of Veterans Affairs: Diagnostic- and Symptom-Guided Drug Selection
The DOI matches its Crossref record.
Abstract
BACKGROUND: Although increasing numbers of war veterans are seeking treatment for posttraumatic stress disorder (PTSD) at the U.S. Department of Veterans Affairs (VA), information on the role of psychotropic pharmacotherapy in their treatment has not been available. METHOD: Records of psychotropic prescriptions for all VA patients diagnosed with ICD-9 PTSD (N = 274,297) in fiscal year 2004 (October 1, 2003, to September 30, 2004) were examined. Descriptive statistics and multivariable logistic regression were used to identify veteran characteristics and measures of service use that were associated with receipt of any psychotropic medication and, among users of such medications, with use of each of 3 medication classes: antidepressants, anxiolytics/sedative-hypnotics, and antipsychotics. RESULTS: Most veterans diagnosed with PTSD received psychotropic medication (80%), and among these, 89% were prescribed antidepressants, 61% anxiolytics/sedative-hypnotics, and 34% antipsychotics. Greater likelihood of medication use was associated with greater mental health service use and comorbid psychiatric disorders. Among comorbidities, medication-appropriate comorbid diagnoses were the most robust predictors of use of each of the 3 medication subclasses, i.e., depressive disorders were associated with antidepressant use, anxiety disorders with anxiolytic/sedative-hypnotic use, and psychotic disorders with antipsychotic use. Use of anxiolytics/sedative-hypnotics and antipsychotics in the absence of a clearly indicated diagnosis was substantial. CONCLUSIONS: Diverse psychotropic medication classes are extensively used in the treatment of PTSD in the VA. While disease-specific use for both PTSD and comorbid disorders is common, substantial use seems to be unrelated to diagnosis and thus is likely to be targeted at specific symptoms (e.g., insomnia, anxiety, nightmares, and flashbacks) rather than diagnosed illnesses. A new type of efficacy research may be needed to determine symptom responses to psychotropic medications as well as disorder responses, perhaps across diagnoses.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Still being checked.
Cited by
Items 101–114 of 114
Hicks, P. B. (2008) · Defense Technical Information Center (DTIC) · doi:10.21236/ada488880
La asociación psiquiátrica de América Latina
Rojas, R. N. C. (2014) · Revista Colombiana de Psiquiatría · doi:10.1016/j.rcp.2014.06.001
Venter, H. (2014) · International journal of advances in psychology · doi:10.14355/ijap.2014.0301.01
Maples‐Keller, J. L., & Rauch, S. A. M. (2017) · Clinical Psychology Science and Practice · doi:10.1111/cpsp.12204
Is There a Role for Second Generation Antipsychotics in the Treatment of PTSD?
Villarreal, G. (2017) · Journal of Trauma & Treatment · doi:10.4172/2167-1222.1000406
[Side effects of homologous transfusion].
Schütt, K.-H., & Arndt‐Hanser, A. (1988) · PubMed
Vercillo, E., Santone, G., & Carnevali, R. (2019) · QUADERNI DI PSICOTERAPIA COGNITIVA · doi:10.3280/qpc2018-043002
Mello, M. F., Ameringen, M. V., Patterson, B. A., & Stein, M. B. (2011) · Wiley eBooks · doi:10.1002/9781119998471.ch4a
Chapter 51. Treatment of Posttraumatic Stress Disorder
Nemeroff, C. B., Rosen, V., & Ortiz, N. F. (2024) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781615375523.as51
Effectiveness of Pharmacological Treatment for PTSD: A Systematic Review
Vyas, D., Tripathi, S., & Goel, D. (2025) · Advances in medical diagnosis, treatment, and care (AMDTC) book series · doi:10.4018/979-8-3693-7432-0.ch022
PTSD, cannabis use, and expected symptom relief: gender-moderated mediational effects
Ueno, L. F. (2023) · Scholars Archive - University at Albany (University at Albany, State University of New York) · doi:10.54014/n5dz-yakb
Higher Risk — Less Research? Addressing the Gender Data Gap in Psychotraumatology
Haering, S. (2025) · Refubium (Universitätsbibliothek der Freien Universität Berlin) · doi:10.17169/refubium-47107
Emtyazi, D. (2023) · TSpace (University of Toronto) · Cited by 2
Confue, J., Maidment, I., & Jones, M. D. (2026) · BMC Psychiatry · doi:10.1186/s12888-026-08104-y
Metadata
- Authors
- Mohamed, S., & Rosenheck, R. A.
- Affiliations
- United States Department of Veterans Affairs (US)
- Venue
- The Journal of Clinical Psychiatry
- Publisher
- Physicians Postgraduate Press, Inc
- Published
- 2008-06-15
- Volume
- 69
- Issue
- 6
- Pages
- 959-965
- ISSN
- 0160-6689 (ISSN-L)
- OpenAlex
- W1968519392
- Cited by
- 115
- References
- 0
- Citations by year
- 2026: 1 · 2025: 1 · 2024: 3 · 2023: 4 · 2022: 5 · 2021: 3 · 2020: 4 · 2019: 6 · 2018: 6 · 2017: 14 · 2016: 4 · 2015: 11 · 2014: 7 · 2013: 10 · 2012: 10
- FWCI
- 9.31
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Social Sciences › Psychology › Clinical Psychology › Posttraumatic Stress Disorder Research
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Sleep and related disorders
- Social Sciences › Psychology › Clinical Psychology › Migration, Health and Trauma
- Keywords
- post-traumatic stress disorder, psychotropic drugs, antidepressants, anxiolytics, sedative-hypnotic drugs, antipsychotic drugs, veterans, Department of Veterans Affairs, psychiatric comorbidity, mental health service utilization, prescribing patterns, insomnia, nightmares, flashbacks
- MeSH terms
- Anxiety, Drug Therapy, Female, Humans, Hypnotics and Sedatives, Sleep Initiation and Maintenance Disorders, Male, Middle Aged, Psychotropic Drugs, Stress Disorders, Post-Traumatic, Antipsychotic Agents, Anti-Anxiety Agents, United States, United States Department of Veterans Affairs, Comorbidity, International Classification of Diseases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.